Facial infiltrating lipomatosis with contralateral hemimegalencephaly.
Chen H, Sun B, Hua C, Lin X.
Seizure. 2024 Dec;123:34-36. doi: 10.1016/j.seizure.2024.10.010. Epub 2024 Oct 17.
PMID:39454530
PIK3CA-Related Overgrowth Spectrum.
Mirzaa G, Graham JM Jr, Keppler-Noreuil K.
2013 Aug 15 [updated 2023 Apr 6]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.
PMID:23946963
Clinical characteristics and surgical management of facial infiltrating lipomatosis: a single center experience.
Chen H, Sun B, Xia W, Qiu Y, Gao W, Hua C, Lin X.
Head Face Med. 2024 Feb 20;20(1):13. doi: 10.1186/s13005-024-00412-6.
PMID:38378686
Congenital Facial Infiltrating Lipomatosis: A Rare Cause of Facial Asymmetry in Infants.
El Omri M, Mouna B, Safa J, Zeineb N, Monia G, Jihene H, Wassim K.
Ear Nose Throat J. 2024 Apr 1:1455613241241869. doi: 10.1177/01455613241241869. Online ahead of print.
PMID:38561952
H3K18 lactylation-hexokinase 2 positive feedback loop promotes osteogenesis of ASPCs in facial infiltrating lipomatosis.
Chen H, Hua C, Chang SJ, Qiu Y, Lin X, Sun B.
Stem Cell Res Ther. 2025 Oct 1;16(1):538. doi: 10.1186/s13287-025-04651-5.
PMID:41035068
Encephalocraniocutaneous Lipomatosis.
Bavle A, Shah R, Gross N, Gavula T, Ruiz-Elizalde A, Wierenga K, McNall-Knapp R.
Facial infiltrating lipomatosis with hemimegalencephaly and lymphatic malformations caused by nonhotspot phosphatidylinositol 3-kinase catalytic subunit alpha mutation.
Chen H, Sun B, Gao W, Jia H, Zhou L, Hua C, Lin X.
Pediatr Dermatol. 2023 Nov-Dec;40(6):1115-1119. doi: 10.1111/pde.15346. Epub 2023 May 15.
PMID:37190882
Hyperactivation of the m(6)A demethylase FTO to down-regulate SLC7A11/xCT-mediated redox homeostasis and epigenetic remodeling in facial infiltrating lipomatosis.
Chen H, Gao W, Huang Z, Chang SJ, Qiu Y, Sun B, Lin X, Hua C.